zaza1
Posted - 1 hour ago
$NVCR I lost here lots of money, and I am not sure if I need to sell and go away. Do you have any thoughts ?
I know honest people that are working nvcr saying it's a great company with bright future..
zaza1
Posted - 5 hours ago
$NVCR, so if there is no future here, why is the institual hold almost 90%?
zaza1
Posted - 1 day ago
$NVCR, everybody is bullish here?
No pulse..
1.5 billion company no one writes
TJmaximus
Posted - 1 day ago
$NVCR Mgmt bragging about building shareholder value...
zaza1
Posted - 1 day ago
$NVCR management needs to be bought now.
TJmaximus
Posted - 1 day ago
$NVCR commercial TTF research institute
zaza1
Posted - 1 day ago
$NVCR, hopefully we get some correction today. Wish to see 20$ soon.
Captaingrey
Posted - 1 day ago
$NVCR jason bednar pump try
trader_b1
Posted - 2 days ago
$NVCR If you are a NVCR perma-bull then price is at a good point to double and triple down. If support doesn't hold you can get out with minor losses. But as I've said before this is still a swing trade, not a buy and hold, ie not a place where perma-bulls do well. In contrast, every trip up is another 25% gain as a swing trade, compared to actual losses or opportunity costs for buy/hold investors. Beware.....While price is near support, the market appears to be correcting as expected and NVCR is a very weak stock. If the market rolls over, support may not hold. In that case, this could easily test the recent lows at 10.9. So if you buy, be ready to get out if support doesn't hold and be ready to take profits if it goes back toward the top of the blue zone.
zaza1
Posted - 2 days ago
$NVCR, so we go 52 weeks low,
Dam, it's heart me .
MoHernz
Posted - 2 days ago
$NVCR Hoping a closing tsunami don't hit shorty bad. Fresh powder aside. Almost 2 bucks below lowest target level. Load or wait? Both are good right now. Don't chase. Just chew.
zaza1
Posted - 2 days ago
$NVCR buyout is an option?
zaza1
Posted - 2 days ago
$NVCR 15$ EOD.90%institual holding
stygg
Posted - 2 days ago
@SodApOp_P1MPski you mean like this morning dip add? 93,63f62933e1e8f501ad5ff780,$NVCR added a couple more here,2023-02-13T17:39:30Z,"{""sentiment"": null}",512002662,"{""total"": 2, ""user_ids"": [1419594, 1396153]}",[],"{""id"": 2095, ""title"": ""StockTwits For Android "", ""url"": ""http://www.stocktwits.com/mobile""}","[{""id"": 12802, ""symbol"": ""NVCR"", ""symbol_mic"": ""NVCR.XNAS"", ""title"": ""NovoCure Ltd"", ""aliases"": [], ""is_following"": ""false"", ""watchlist_count"": 6769, ""has_pricing"": ""true""}]","{""id"": 2133920, ""username"": ""SodApOp_PIMPski"", ""name"": ""Mike D"", ""avatar_url"": ""https://avatars.stocktwits.com/production/2133920/thumb-1597291570.png"", ""avatar_url_ssl"": ""https://avatars.stocktwits.com/production/2133920/thumb-1597291570.png"", ""join_date"": ""2019-06-11"", ""official"": ""false"", ""identity"": ""User"", ""classification"": [], ""home_country"": ""US"", ""followers"": 183, ""following"": 41, ""ideas"": 21808, ""watchlist_stocks_count"": 73, ""like_count"": 15617, ""plus_tier"": """", ""premium_room"": "", [...]
Kody2
Posted - 2 days ago
$NVCR Novocure reports in about 2 weeks. I expect another meaningless "progress update" on various clinical trials from a management team that has little credibility on Wall Street. I expect another large loss on, once again, stagnant revenues. Most small biotechs getting slammed again. There is a good chance, particularly if the overall market continues to struggle, that Novocure tests its 52-week low just below $11./share.
GordonGecko_was_THE_MAN
Posted - 4 days ago
$NVCR I want to frame some discussion around upcoming Panova Ph3 data. Consider 2 types of risk: A) Will trial hit primary endpoint? B) Will trial data be useful for successful sales for the given indication given all competitive alternatives? NVCR track record for type A risk is actually quite successful, consider: 1) EF14 (GBM): hit primary endpoint 2) Lunar (2L lung): hit primary endpoint with shortened / shrunken trial per DMC 3) Ovarian: failed primary endpoint (NVCR now says too many patients were on dox, which lowers electrical conductivity of tissue surrounding tumor, thus neutralizing TTF effect) 4) Metis: hit primary endpoint This the actual trial data: 3/4 last ph3 NVCR trials hit their primary endpoint with clear stat sig. Remember, FDA approval for mesothelioma was based only on the ph2 data (no ph3 trial was run). I would argue NVCR wasted plenty of energy pursuing meso, but at least they didn’t invest in a ph3 trial.
Dicknarse
Posted - 4 days ago
$NVCR garbage on a platter
trader_b1
Posted - 5 days ago
$NVCR SMH. Interesting how some longs are just as excited when price goes up as when it goes down (and some shorts do the same).
MoHernz
Posted - 5 days ago
$NVCR Pushing hard in that 14 line!!
khmerxbxboi
Posted - 5 days ago
$GME $PARA $SAVE $NVCR = Before Summer which one will give us that 100% run?
TJmaximus
Posted - 5 days ago
$NVCR commercial TTF research institute:
TJmaximus
Posted - 6 days ago
$NVCR where are those new arrays? asking for Blackjack.
MoHernz
Posted - 6 days ago
$NVCR My average price still @ high 13, and ain't selling. We will bounce "pritty" again. Diamond hands. Don't sell, don't feed shorty
MoHernz
Posted - 6 days ago
$NVCR Steady above the 14 mark. We should see 16 again next week. Friday might get bumpy, but shorty struggles @ da 14 mark. That's a good sign though. Bottom is being defined. GLTYA
MoHernz
Posted - 6 days ago
$NVCR Shoot...gave away your shares. Rally and avg price fades away. Back to square 1. Soon on the 13. Stop selling, stop the 🩸 bleeding. Shorty is reloading
Tdorsey1776
Posted - 6 days ago
$NVCR Norges Bank bought a new position in NovoCure during the 4th quarter worth $71,417,000. BlackRock Inc. boosted its stake in NovoCure by 9.5% in the first quarter. BlackRock Inc. now owns 8,324,921 shares of the medical equipment provider's stock valued at $500,661,000 after buying an additional 719,265 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of NovoCure by 22.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,655,686 shares of the medical equipment provider's stock worth $159,714,000 after purchasing an additional 487,255 shares during the period.
MoHernz
Posted - 1 week ago
$NVCR Oughta dance 15.50 - 2-morrow...